img

Global African Horse Sickness Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global African Horse Sickness Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Recommendations for African horse sickness vaccines for use in nonendemic areas
The global African Horse Sickness Vaccines market size was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034.
The United States market for African Horse Sickness Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for African Horse Sickness Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for African Horse Sickness Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034..
The global key manufacturers of African Horse Sickness Vaccines include Biopharma, Onderstepoort Biological Products and Veterinary Serum and Vaccine Research Institute, etc. In 2022, the global top five players hold a share approximately % in sales volume, and in term of revenue of African Horse Sickness Vaccines, the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of African Horse Sickness Vaccines by regions (Countries), company, by type and by type. from 2018 to 2024 and forecast to 2034.
The global African Horse Sickness Vaccines market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global African Horse Sickness Vaccines market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


Biopharma
Onderstepoort Biological Products
Veterinary Serum and Vaccine Research Institute
By Type
Live Vaccines
Killed Vaccines
By Application
Horses
Mules
Donkeys
Sales by Region
North America
the United States
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
UK
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of African Horse Sickness Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of African Horse Sickness Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, African Horse Sickness Vaccines sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 African Horse Sickness Vaccines Definition
1.2 Market by Type
1.2.1 Global African Horse Sickness Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Live Vaccines
1.2.3 Killed Vaccines
1.3 Market Segment by Application
1.3.1 Global African Horse Sickness Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Horses
1.3.3 Mules
1.3.4 Donkeys
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global African Horse Sickness Vaccines Sales
2.1 Global African Horse Sickness Vaccines Revenue Estimates and Forecasts 2018-2034
2.2 Global African Horse Sickness Vaccines Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global African Horse Sickness Vaccines Revenue by Region
2.3.1 Global African Horse Sickness Vaccines Revenue by Region (2018-2024)
2.3.2 Global African Horse Sickness Vaccines Revenue by Region (2024-2034)
2.4 Global African Horse Sickness Vaccines Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global African Horse Sickness Vaccines Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global African Horse Sickness Vaccines Sales Quantity by Region
2.6.1 Global African Horse Sickness Vaccines Sales Quantity by Region (2018-2024)
2.6.2 Global African Horse Sickness Vaccines Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global African Horse Sickness Vaccines Sales Quantity by Manufacturers
3.1.1 Global African Horse Sickness Vaccines Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global African Horse Sickness Vaccines Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by African Horse Sickness Vaccines Sales in 2022
3.2 Global African Horse Sickness Vaccines Revenue by Manufacturers
3.2.1 Global African Horse Sickness Vaccines Revenue by Manufacturers (2018-2024)
3.2.2 Global African Horse Sickness Vaccines Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by African Horse Sickness Vaccines Revenue in 2022
3.3 Global African Horse Sickness Vaccines Sales Price by Manufacturers
3.4 Global Key Players of African Horse Sickness Vaccines, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global African Horse Sickness Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of African Horse Sickness Vaccines, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of African Horse Sickness Vaccines, Product Offered and Application
3.8 Global Key Manufacturers of African Horse Sickness Vaccines, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global African Horse Sickness Vaccines Sales Quantity by Type
4.1.1 Global African Horse Sickness Vaccines Historical Sales Quantity by Type (2018-2024)
4.1.2 Global African Horse Sickness Vaccines Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global African Horse Sickness Vaccines Sales Quantity Market Share by Type (2018-2034)
4.2 Global African Horse Sickness Vaccines Revenue by Type
4.2.1 Global African Horse Sickness Vaccines Historical Revenue by Type (2018-2024)
4.2.2 Global African Horse Sickness Vaccines Forecasted Revenue by Type (2024-2034)
4.2.3 Global African Horse Sickness Vaccines Revenue Market Share by Type (2018-2034)
4.3 Global African Horse Sickness Vaccines Price by Type
4.3.1 Global African Horse Sickness Vaccines Price by Type (2018-2024)
4.3.2 Global African Horse Sickness Vaccines Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global African Horse Sickness Vaccines Sales Quantity by Application
5.1.1 Global African Horse Sickness Vaccines Historical Sales Quantity by Application (2018-2024)
5.1.2 Global African Horse Sickness Vaccines Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global African Horse Sickness Vaccines Sales Quantity Market Share by Application (2018-2034)
5.2 Global African Horse Sickness Vaccines Revenue by Application
5.2.1 Global African Horse Sickness Vaccines Historical Revenue by Application (2018-2024)
5.2.2 Global African Horse Sickness Vaccines Forecasted Revenue by Application (2024-2034)
5.2.3 Global African Horse Sickness Vaccines Revenue Market Share by Application (2018-2034)
5.3 Global African Horse Sickness Vaccines Price by Application
5.3.1 Global African Horse Sickness Vaccines Price by Application (2018-2024)
5.3.2 Global African Horse Sickness Vaccines Price Forecast by Application (2024-2034)
6 North America
6.1 North America African Horse Sickness Vaccines Sales by Company
6.1.1 North America African Horse Sickness Vaccines Revenue by Company (2018-2024)
6.1.2 North America African Horse Sickness Vaccines Sales Quantity by Company (2018-2024)
6.2 North America African Horse Sickness Vaccines Market Size by Type
6.2.1 North America African Horse Sickness Vaccines Sales Quantity by Type (2018-2034)
6.2.2 North America African Horse Sickness Vaccines Revenue by Type (2018-2034)
6.3 North America African Horse Sickness Vaccines Market Size by Application
6.3.1 North America African Horse Sickness Vaccines Sales Quantity by Application (2018-2034)
6.3.2 North America African Horse Sickness Vaccines Revenue by Application (2018-2034)
6.4 North America African Horse Sickness Vaccines Market Size by Country
6.4.1 North America African Horse Sickness Vaccines Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America African Horse Sickness Vaccines Revenue by Country (2018-2034)
6.4.3 North America African Horse Sickness Vaccines Sales Quantity by Country (2018-2034)
6.4.4 the United States
6.4.5 Canada
7 Europe
7.1 Europe African Horse Sickness Vaccines Sales by Company
7.1.1 Europe African Horse Sickness Vaccines Sales Quantity by Company (2018-2024)
7.1.2 Europe African Horse Sickness Vaccines Revenue by Company (2018-2024)
7.2 Europe African Horse Sickness Vaccines Market Size by Type
7.2.1 Europe African Horse Sickness Vaccines Sales Quantity by Type (2018-2034)
7.2.2 Europe African Horse Sickness Vaccines Revenue by Type (2018-2034)
7.3 Europe African Horse Sickness Vaccines Market Size by Application
7.3.1 Europe African Horse Sickness Vaccines Sales Quantity by Application (2018-2034)
7.3.2 Europe African Horse Sickness Vaccines Revenue by Application (2018-2034)
7.4 Europe African Horse Sickness Vaccines Market Size by Country
7.4.1 Europe African Horse Sickness Vaccines Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe African Horse Sickness Vaccines Revenue by Country (2018-2034)
7.4.3 Europe African Horse Sickness Vaccines Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 UK
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China African Horse Sickness Vaccines Sales by Company
8.1.1 China African Horse Sickness Vaccines Sales Quantity by Company (2018-2024)
8.1.2 China African Horse Sickness Vaccines Revenue by Company (2018-2024)
8.2 China African Horse Sickness Vaccines Market Size by Type
8.2.1 China African Horse Sickness Vaccines Sales Quantity by Type (2018-2034)
8.2.2 China African Horse Sickness Vaccines Revenue by Type (2018-2034)
8.3 China African Horse Sickness Vaccines Market Size by Application
8.3.1 China African Horse Sickness Vaccines Sales Quantity by Application (2018-2034)
8.3.2 China African Horse Sickness Vaccines Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC African Horse Sickness Vaccines Sales by Company
9.1.1 APAC African Horse Sickness Vaccines Sales Quantity by Company (2018-2024)
9.1.2 APAC African Horse Sickness Vaccines Revenue by Company (2018-2024)
9.2 APAC African Horse Sickness Vaccines Market Size by Type
9.2.1 APAC African Horse Sickness Vaccines Sales Quantity by Type (2018-2034)
9.2.2 APAC African Horse Sickness Vaccines Revenue by Type (2018-2034)
9.3 APAC African Horse Sickness Vaccines Market Size by Application
9.3.1 APAC African Horse Sickness Vaccines Sales Quantity by Application (2018-2034)
9.3.2 APAC African Horse Sickness Vaccines Revenue by Application (2018-2034)
9.4 APAC African Horse Sickness Vaccines Market Size by Region
9.4.1 APAC African Horse Sickness Vaccines Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC African Horse Sickness Vaccines Revenue by Region (2018-2034)
9.4.3 APAC African Horse Sickness Vaccines Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America African Horse Sickness Vaccines Sales by Company
10.1.1 Middle East, Africa and Latin America African Horse Sickness Vaccines Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America African Horse Sickness Vaccines Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America African Horse Sickness Vaccines Market Size by Type
10.2.1 Middle East, Africa and Latin America African Horse Sickness Vaccines Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America African Horse Sickness Vaccines Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America African Horse Sickness Vaccines Market Size by Application
10.3.1 Middle East, Africa and Latin America African Horse Sickness Vaccines Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America African Horse Sickness Vaccines Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America African Horse Sickness Vaccines Market Size by Country
10.4.1 Middle East, Africa and Latin America African Horse Sickness Vaccines Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America African Horse Sickness Vaccines Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America African Horse Sickness Vaccines Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Biopharma
11.1.1 Biopharma Company Information
11.1.2 Biopharma Overview
11.1.3 Biopharma African Horse Sickness Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 Biopharma African Horse Sickness Vaccines Products and Services
11.1.5 Biopharma African Horse Sickness Vaccines SWOT Analysis
11.1.6 Biopharma Recent Developments
11.2 Onderstepoort Biological Products
11.2.1 Onderstepoort Biological Products Company Information
11.2.2 Onderstepoort Biological Products Overview
11.2.3 Onderstepoort Biological Products African Horse Sickness Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 Onderstepoort Biological Products African Horse Sickness Vaccines Products and Services
11.2.5 Onderstepoort Biological Products African Horse Sickness Vaccines SWOT Analysis
11.2.6 Onderstepoort Biological Products Recent Developments
11.3 Veterinary Serum and Vaccine Research Institute
11.3.1 Veterinary Serum and Vaccine Research Institute Company Information
11.3.2 Veterinary Serum and Vaccine Research Institute Overview
11.3.3 Veterinary Serum and Vaccine Research Institute African Horse Sickness Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 Veterinary Serum and Vaccine Research Institute African Horse Sickness Vaccines Products and Services
11.3.5 Veterinary Serum and Vaccine Research Institute African Horse Sickness Vaccines SWOT Analysis
11.3.6 Veterinary Serum and Vaccine Research Institute Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 African Horse Sickness Vaccines Value Chain Analysis
12.2 African Horse Sickness Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 African Horse Sickness Vaccines Production Mode & Process
12.4 African Horse Sickness Vaccines Sales and Marketing
12.4.1 African Horse Sickness Vaccines Sales Channels
12.4.2 African Horse Sickness Vaccines Distributors
12.5 African Horse Sickness Vaccines Customers
13 Market Dynamics
13.1 African Horse Sickness Vaccines Industry Trends
13.2 African Horse Sickness Vaccines Market Drivers
13.3 African Horse Sickness Vaccines Market Challenges
13.4 African Horse Sickness Vaccines Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global African Horse Sickness Vaccines Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Live Vaccines
Table 3. Major Manufacturers of Killed Vaccines
Table 4. Global African Horse Sickness Vaccines Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global African Horse Sickness Vaccines Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global African Horse Sickness Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global African Horse Sickness Vaccines Revenue Market Share by Region (2018-2024)
Table 8. Global African Horse Sickness Vaccines Revenue by Region (2024-2034) & (US$ Million)
Table 9. Global African Horse Sickness Vaccines Revenue Market Share by Region (2024-2034)
Table 10. Global African Horse Sickness Vaccines Sales Quantity by Region: 2018 VS 2022 VS 2034 (K Units)
Table 11. Global African Horse Sickness Vaccines Sales by Region (2018-2024) & (K Units)
Table 12. Global African Horse Sickness Vaccines Sales Market Share by Region (2018-2024)
Table 13. Global African Horse Sickness Vaccines Sales by Region (2024-2034) & (K Units)
Table 14. Global African Horse Sickness Vaccines Sales Market Share by Region (2024-2034)
Table 15. Global African Horse Sickness Vaccines Sales Quantity by Manufacturers (2018-2024) & (K Units)
Table 16. Global African Horse Sickness Vaccines Sales Quantity Share by Manufacturers (2018-2024)
Table 17. Global African Horse Sickness Vaccines Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global African Horse Sickness Vaccines Revenue Share by Manufacturers (2018-2024)
Table 19. Global African Horse Sickness Vaccines Price by Manufacturers 2018-2024 (USD/Unit)
Table 20. Global Key Players of African Horse Sickness Vaccines, Industry Ranking, 2021 VS 2022
Table 21. Global African Horse Sickness Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global African Horse Sickness Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in African Horse Sickness Vaccines as of 2022)
Table 23. Global Key Manufacturers of African Horse Sickness Vaccines, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of African Horse Sickness Vaccines, Product Offered and Application
Table 25. Global Key Manufacturers of African Horse Sickness Vaccines, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global African Horse Sickness Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 28. Global African Horse Sickness Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 29. Global African Horse Sickness Vaccines Sales Quantity Share by Type (2018-2024)
Table 30. Global African Horse Sickness Vaccines Sales Quantity Share by Type (2024-2034)
Table 31. Global African Horse Sickness Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global African Horse Sickness Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 33. Global African Horse Sickness Vaccines Revenue Share by Type (2018-2024)
Table 34. Global African Horse Sickness Vaccines Revenue Share by Type (2024-2034)
Table 35. African Horse Sickness Vaccines Price by Type (2018-2024) & (USD/Unit)
Table 36. Global African Horse Sickness Vaccines Price Forecast by Type (2024-2034) & (USD/Unit)
Table 37. Global African Horse Sickness Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 38. Global African Horse Sickness Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 39. Global African Horse Sickness Vaccines Sales Quantity Share by Application (2018-2024)
Table 40. Global African Horse Sickness Vaccines Sales Quantity Share by Application (2024-2034)
Table 41. Global African Horse Sickness Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global African Horse Sickness Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 43. Global African Horse Sickness Vaccines Revenue Share by Application (2018-2024)
Table 44. Global African Horse Sickness Vaccines Revenue Share by Application (2024-2034)
Table 45. African Horse Sickness Vaccines Price by Application (2018-2024) & (USD/Unit)
Table 46. Global African Horse Sickness Vaccines Price Forecast by Application (2024-2034) & (USD/Unit)
Table 47. North America African Horse Sickness Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 48. North America African Horse Sickness Vaccines Sales Quantity by Company (2018-2024) & (K Units)
Table 49. North America African Horse Sickness Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 50. North America African Horse Sickness Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 51. North America African Horse Sickness Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 52. North America African Horse Sickness Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 53. North America African Horse Sickness Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 54. North America African Horse Sickness Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 55. North America African Horse Sickness Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 56. North America African Horse Sickness Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 57. North America African Horse Sickness Vaccines Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 58. North America African Horse Sickness Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 59. North America African Horse Sickness Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 60. North America African Horse Sickness Vaccines Sales Quantity by Country (2018-2024) & (K Units)
Table 61. North America African Horse Sickness Vaccines Sales Quantity by Country (2024-2034) & (K Units)
Table 62. Europe African Horse Sickness Vaccines Sales Quantity by Company (2018-2024) & (K Units)
Table 63. Europe African Horse Sickness Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 64. Europe African Horse Sickness Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 65. Europe African Horse Sickness Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 66. Europe African Horse Sickness Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 67. Europe African Horse Sickness Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 68. Europe African Horse Sickness Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 69. Europe African Horse Sickness Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 70. Europe African Horse Sickness Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 71. Europe African Horse Sickness Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 72. Europe African Horse Sickness Vaccines Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 73. Europe African Horse Sickness Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 74. Europe African Horse Sickness Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 75. Europe African Horse Sickness Vaccines Sales Quantity by Country (2018-2024) & (K Units)
Table 76. Europe African Horse Sickness Vaccines Sales Quantity by Country (2024-2034) & (K Units)
Table 77. China African Horse Sickness Vaccines Sales Quantity by Company (2018-2024) & (K Units)
Table 78. China African Horse Sickness Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 79. China African Horse Sickness Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 80. China African Horse Sickness Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 81. China African Horse Sickness Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 82. China African Horse Sickness Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 83. China African Horse Sickness Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 84. China African Horse Sickness Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 85. China African Horse Sickness Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 86. China African Horse Sickness Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 87. APAC African Horse Sickness Vaccines Sales Quantity by Company (2018-2024) & (K Units)
Table 88. APAC African Horse Sickness Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 89. APAC African Horse Sickness Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 90. APAC African Horse Sickness Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 91. APAC African Horse Sickness Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 92. APAC African Horse Sickness Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 93. APAC African Horse Sickness Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 94. APAC African Horse Sickness Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 95. APAC African Horse Sickness Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 96. APAC African Horse Sickness Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 97. APAC African Horse Sickness Vaccines Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 98. APAC African Horse Sickness Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 99. APAC African Horse Sickness Vaccines Revenue by Region (2024-2034) & (US$ Million)
Table 100. APAC African Horse Sickness Vaccines Sales Quantity by Region (2018-2024) & (K Units)
Table 101. APAC African Horse Sickness Vaccines Sales Quantity by Region (2024-2034) & (K Units)
Table 102. Middle East, Africa and Latin America African Horse Sickness Vaccines Sales Quantity by Company (2018-2024) & (K Units)
Table 103. Middle East, Africa and Latin America African Horse Sickness Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America African Horse Sickness Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 105. Middle East, Africa and Latin America African Horse Sickness Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 106. Middle East, Africa and Latin America African Horse Sickness Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America African Horse Sickness Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 108. Middle East, Africa and Latin America African Horse Sickness Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 109. Middle East, Africa and Latin America African Horse Sickness Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 110. Middle East, Africa and Latin America African Horse Sickness Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 111. Middle East, Africa and Latin America African Horse Sickness Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 112. Middle East, Africa and Latin America African Horse Sickness Vaccines Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 113. Middle East, Africa and Latin America African Horse Sickness Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 114. Middle East, Africa and Latin America African Horse Sickness Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America African Horse Sickness Vaccines Sales Quantity by Country (2018-2024) & (K Units)
Table 116. Middle East, Africa and Latin America African Horse Sickness Vaccines Sales Quantity by Country (2024-2034) & (K Units)
Table 117. Biopharma Company Information
Table 118. Biopharma Description and Overview
Table 119. Biopharma African Horse Sickness Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 120. Biopharma African Horse Sickness Vaccines Product and Services
Table 121. Biopharma African Horse Sickness Vaccines SWOT Analysis
Table 122. Biopharma Recent Developments
Table 123. Onderstepoort Biological Products Company Information
Table 124. Onderstepoort Biological Products Description and Overview
Table 125. Onderstepoort Biological Products African Horse Sickness Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 126. Onderstepoort Biological Products African Horse Sickness Vaccines Product and Services
Table 127. Onderstepoort Biological Products African Horse Sickness Vaccines SWOT Analysis
Table 128. Onderstepoort Biological Products Recent Developments
Table 129. Veterinary Serum and Vaccine Research Institute Company Information
Table 130. Veterinary Serum and Vaccine Research Institute Description and Overview
Table 131. Veterinary Serum and Vaccine Research Institute African Horse Sickness Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 132. Veterinary Serum and Vaccine Research Institute African Horse Sickness Vaccines Product and Services
Table 133. Veterinary Serum and Vaccine Research Institute African Horse Sickness Vaccines SWOT Analysis
Table 134. Veterinary Serum and Vaccine Research Institute Recent Developments
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. African Horse Sickness Vaccines Distributors List
Table 138. African Horse Sickness Vaccines Customers List
Table 139. African Horse Sickness Vaccines Market Trends
Table 140. African Horse Sickness Vaccines Market Drivers
Table 141. African Horse Sickness Vaccines Market Challenges
Table 142. African Horse Sickness Vaccines Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. African Horse Sickness Vaccines Product Picture
Figure 2. Global African Horse Sickness Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global African Horse Sickness Vaccines Market Share by Type in 2022 & 2034
Figure 4. Live Vaccines Product Picture
Figure 5. Killed Vaccines Product Picture
Figure 6. Global African Horse Sickness Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 7. Global African Horse Sickness Vaccines Market Share by Application in 2022 & 2034
Figure 8. Horses
Figure 9. Mules
Figure 10. Donkeys
Figure 11. African Horse Sickness Vaccines Report Years Considered
Figure 12. Global African Horse Sickness Vaccines Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 13. Global African Horse Sickness Vaccines Revenue 2018-2034 (US$ Million)
Figure 14. Global African Horse Sickness Vaccines Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 15. Global African Horse Sickness Vaccines Sales Quantity 2018-2034 (K Units)
Figure 16. Global African Horse Sickness Vaccines Sales Quantity Market Share by Region (2018-2024)
Figure 17. Global African Horse Sickness Vaccines Sales Quantity Market Share by Region (2024-2034)
Figure 18. North America African Horse Sickness Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 19. North America African Horse Sickness Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 20. Europe African Horse Sickness Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 21. Europe African Horse Sickness Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 22. China African Horse Sickness Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 23. China African Horse Sickness Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 24. APAC African Horse Sickness Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 25. APAC African Horse Sickness Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 26. Middle East, Africa and Latin America African Horse Sickness Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 27. Middle East, Africa and Latin America African Horse Sickness Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 28. The Top 10 and Top 5 Players Market Share by African Horse Sickness Vaccines Sales Quantity in 2022
Figure 29. The Top 10 and Top 5 Players Market Share by African Horse Sickness Vaccines Revenue in 2022
Figure 30. African Horse Sickness Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global African Horse Sickness Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 32. Global African Horse Sickness Vaccines Revenue Market Share by Type (2018-2034)
Figure 33. Global African Horse Sickness Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 34. Global African Horse Sickness Vaccines Revenue Market Share by Application (2018-2034)
Figure 35. North America African Horse Sickness Vaccines Revenue Market Share by Company in 2022
Figure 36. North America African Horse Sickness Vaccines Sales Quantity Market Share by Company in 2022
Figure 37. North America African Horse Sickness Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 38. North America African Horse Sickness Vaccines Revenue Market Share by Type (2018-2034)
Figure 39. North America African Horse Sickness Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 40. North America African Horse Sickness Vaccines Revenue Market Share by Application (2018-2034)
Figure 41. North America African Horse Sickness Vaccines Revenue Share by Country (2018-2034)
Figure 42. North America African Horse Sickness Vaccines Sales Quantity Share by Country (2018-2034)
Figure 43. the United States African Horse Sickness Vaccines Revenue (2018-2034) & (US$ Million)
Figure 44. Canada African Horse Sickness Vaccines Revenue (2018-2034) & (US$ Million)
Figure 45. Europe African Horse Sickness Vaccines Sales Quantity Market Share by Company in 2022
Figure 46. Europe African Horse Sickness Vaccines Revenue Market Share by Company in 2022
Figure 47. Europe African Horse Sickness Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 48. Europe African Horse Sickness Vaccines Revenue Market Share by Type (2018-2034)
Figure 49. Europe African Horse Sickness Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 50. Europe African Horse Sickness Vaccines Revenue Market Share by Application (2018-2034)
Figure 51. Europe African Horse Sickness Vaccines Revenue Share by Country (2018-2034)
Figure 52. Europe African Horse Sickness Vaccines Sales Quantity Share by Country (2018-2034)
Figure 53. Germany African Horse Sickness Vaccines Revenue (2018-2034) & (US$ Million)
Figure 54. France African Horse Sickness Vaccines Revenue (2018-2034) & (US$ Million)
Figure 55. UK African Horse Sickness Vaccines Revenue (2018-2034) & (US$ Million)
Figure 56. Italy African Horse Sickness Vaccines Revenue (2018-2034) & (US$ Million)
Figure 57. Russia African Horse Sickness Vaccines Revenue (2018-2034) & (US$ Million)
Figure 58. China African Horse Sickness Vaccines Sales Quantity Market Share by Company in 2022
Figure 59. China African Horse Sickness Vaccines Revenue Market Share by Company in 2022
Figure 60. China African Horse Sickness Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 61. China African Horse Sickness Vaccines Revenue Market Share by Type (2018-2034)
Figure 62. China African Horse Sickness Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 63. China African Horse Sickness Vaccines Revenue Market Share by Application (2018-2034)
Figure 64. APAC African Horse Sickness Vaccines Sales Quantity Market Share by Company in 2022
Figure 65. APAC African Horse Sickness Vaccines Revenue Market Share by Company in 2022
Figure 66. APAC African Horse Sickness Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 67. APAC African Horse Sickness Vaccines Revenue Market Share by Type (2018-2034)
Figure 68. APAC African Horse Sickness Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 69. APAC African Horse Sickness Vaccines Revenue Market Share by Application (2018-2034)
Figure 70. APAC African Horse Sickness Vaccines Revenue Share by Region (2018-2034)
Figure 71. APAC African Horse Sickness Vaccines Sales Quantity Share by Region (2018-2034)
Figure 72. Japan African Horse Sickness Vaccines Revenue (2018-2034) & (US$ Million)
Figure 73. South Korea African Horse Sickness Vaccines Revenue (2018-2034) & (US$ Million)
Figure 74. China Taiwan African Horse Sickness Vaccines Revenue (2018-2034) & (US$ Million)
Figure 75. Southeast Asia African Horse Sickness Vaccines Revenue (2018-2034) & (US$ Million)
Figure 76. India African Horse Sickness Vaccines Revenue (2018-2034) & (US$ Million)
Figure 77. Middle East, Africa and Latin America African Horse Sickness Vaccines Sales Quantity Market Share by Company in 2022
Figure 78. Middle East, Africa and Latin America African Horse Sickness Vaccines Revenue Market Share by Company in 2022
Figure 79. Middle East, Africa and Latin America African Horse Sickness Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 80. Middle East, Africa and Latin America African Horse Sickness Vaccines Revenue Market Share by Type (2018-2034)
Figure 81. Middle East, Africa and Latin America African Horse Sickness Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 82. Middle East, Africa and Latin America African Horse Sickness Vaccines Revenue Market Share by Application (2018-2034)
Figure 83. Middle East, Africa and Latin America African Horse Sickness Vaccines Sales Quantity Share by Country (2018-2034)
Figure 84. Middle East, Africa and Latin America African Horse Sickness Vaccines Revenue Share by Country (2018-2034)
Figure 85. Brazil African Horse Sickness Vaccines Revenue (2018-2034) & (US$ Million)
Figure 86. Mexico African Horse Sickness Vaccines Revenue (2018-2034) & (US$ Million)
Figure 87. Turkey African Horse Sickness Vaccines Revenue (2018-2034) & (US$ Million)
Figure 88. Israel African Horse Sickness Vaccines Revenue (2018-2034) & (US$ Million)
Figure 89. GCC Countries African Horse Sickness Vaccines Revenue (2018-2034) & (US$ Million)
Figure 90. African Horse Sickness Vaccines Value Chain
Figure 91. African Horse Sickness Vaccines Production Process
Figure 92. Channels of Distribution (Direct Vs Distribution)
Figure 93. Distributors Profiles
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed